Search results
Swiss National Bank Decreases Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
ETF DAILY NEWS· 4 days agoSwiss National Bank decreased its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 10.2% during the 4th quarter, according to the company in its most recent disclosure ...
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for...
Morningstar· 2 days agoTOKYO and CAMBRIDGE, Mass., May 14, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with...
Benzinga· 4 days agoRegeneron Pharmaceuticals, Inc. REGN and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application ...
Leads Biolabs is Proud to Announce its Participation in the 2024 ASCO Annual Meeting with One Oral...
FOX 4 Kansas City· 4 days agoThe 2024 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from...
Q2 2024 Earnings Forecast for Y-mAbs Therapeutics, Inc. Issued By Wedbush (NASDAQ:YMAB)
ETF DAILY NEWS· 4 days agoY-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) – Equities research analysts at Wedbush lowered their Q2 2024 earnings per share (EPS) estimates for shares of Y-mAbs Therapeutics in a ...
Downbeat mood found among some Mass. residents - The Boston Globe
The Boston Globe· 3 days agoThe long-haul carrier Emirates announced Monday it saw record profits of $4.7 billion in 2023 as the...
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
Rome Sentinel· 1 day agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the appointment of Aleksandra Rizo, M.D ...
Arcus Biosciences (NYSE:RCUS) Shares Gap Up on Better-Than-Expected Earnings
ETF DAILY NEWS· 6 days agoShares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) gapped up before the market opened on Thursday following a stronger than expected earnings report. Arcus Biosciences shares last ...
Sanofi to Spend $1.08 Billion to Boost Drug Production in France
Market Watch· 4 days agoSanofi will spend more than 1 billion euros ($1.08 billion) on ramping up production capability in France. The French pharmaceutical company said Monday that the bulk of the investment will ...
Brussels Regulatory Brief: April 2024
The National Law Review· 1 day agoOn 19 March 2024, the European Commission (Commission) sent a Statement of Objections to a manufacturer and distributor of mineral fibre sandwich panels...